Literature DB >> 16061967

Isolation of human immunodeficiency virus type 1 from semen and vaginal fluids.

Ann A Kiessling1.   

Abstract

Semen and vaginal fluids transmit HIV infection. The virus is present as cell-free particles and as infected cells. Isolation of infectious virus from both genital tract fluids poses unique problems. Vaginal fluids are heavily contaminated with normal bacterial flora, and seminal plasma is cytotoxic to peripheral blood mononuclear cells. Adaptations of routine laboratory procedures have been developed to largely overcome these problems, allowing the culture and characterization of genital-tract HIV.

Entities:  

Mesh:

Year:  2005        PMID: 16061967     DOI: 10.1385/1-59259-907-9:071

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Natural Inhibitor of Human Cytomegalovirus in Human Seminal Plasma.

Authors:  Sina Lippold; Berenike Braun; Franziska Krüger; Mirja Harms; Janis A Müller; Rüdiger Groß; Jan Münch; Jens von Einem
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.

Authors:  Ruizhong Shen; Ernesto R Drelichman; Diane Bimczok; Christina Ochsenbauer; John C Kappes; Jamie A Cannon; Daniela Tudor; Morgane Bomsel; Lesley E Smythies; Phillip D Smith
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

3.  Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer.

Authors:  Seunghee Hong; Eric A Klein; Jaydip Das Gupta; Kirsten Hanke; Christopher J Weight; Carvell Nguyen; Christina Gaughan; Kyeong-Ae Kim; Norbert Bannert; Frank Kirchhoff; Jan Munch; Robert H Silverman
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

4.  Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.

Authors:  Joanna S Olsen; Caitlin Brown; Christina C Capule; Mark Rubinshtein; Todd M Doran; Rajesh K Srivastava; Changyong Feng; Bradley L Nilsson; Jerry Yang; Stephen Dewhurst
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

5.  Utilization of Aminoguanidine Prevents Cytotoxic Effects of Semen.

Authors:  Mirja Harms; Pascal von Maltitz; Rüdiger Groß; Benjamin Mayer; Miriam Deniz; Janis Müller; Jan Münch
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

6.  Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent.

Authors:  Alexey Karetnikov
Journal:  Front Public Health       Date:  2015-08-07

Review 7.  Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants.

Authors:  Susan K Eszterhas; Nicole O Ilonzo; Jennifer E Crozier; Stela Celaj; Alexandra L Howell
Journal:  Infect Dis Rep       Date:  2011-09-07

8.  Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.

Authors:  Shariq M Usmani; Onofrio Zirafi; Janis A Müller; Nathallie L Sandi-Monroy; Jay K Yadav; Christoph Meier; Tanja Weil; Nadia R Roan; Warner C Greene; Paul Walther; K Peter R Nilsson; Per Hammarström; Ronald Wetzel; Christopher D Pilcher; Friedrich Gagsteiger; Marcus Fändrich; Frank Kirchhoff; Jan Münch
Journal:  Nat Commun       Date:  2014-04-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.